new glp-1 drug retatrutide vs Tirzepatide (2026): Differences in Weight Loss, Metabol – Revolution Health & Wellness New GLP-1 obesity drug, retatrutide,

Vasorelaxant effect of glucagon-like peptide-7-36/amide and amylin on the pulmonary circulation of the rat

doi: 10.1111/obr.13841

Some GLP-1 options have also demonstrated cardiovascular benefits, and newer incretin-based medications include dual-agonists (such as GIP/GLP-1) that work similarly but are not exactly the same drug class

CagriSema (cagrilintide/semaglutide) Pending Approval - A combination injectable medication in development, combining cagrilintide and semaglutide to enhance weight loss through appetite suppression

Glucagon-like peptide-1 receptor expression in the human eye

228 PKA, activated by cAMP, can regulate the activity of K-ATP channels in -cells